Eckhardt SG - Search Results

1

Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units.

Hidalgo M, Izbicka E, Eckhardt SG, MacDonald JR, Cerna C, Gomez L, Rowinsky EK, Weitman SD, Von Hoff DD. Hidalgo M, et al. Among authors: eckhardt sg. Anticancer Drugs. 1999 Oct;10(9):837-44. doi: 10.1097/00001813-199910000-00007. Anticancer Drugs. 1999. PMID: 10587294

2

Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units.

Siu LL, Von Hoff DD, Rephaeli A, Izbicka E, Cerna C, Gomez L, Rowinsky EK, Eckhardt SG. Siu LL, et al. Among authors: eckhardt sg. Invest New Drugs. 1998;16(2):113-9. doi: 10.1023/a:1006049227744. Invest New Drugs. 1998. PMID: 9848574

3

Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.

Britten CD, Hilsenbeck SG, Eckhardt SG, Marty J, Mangold G, MacDonald JR, Rowinsky EK, Von Hoff DD, Weitman S. Britten CD, et al. Among authors: eckhardt sg. Cancer Res. 1999 Mar 1;59(5):1049-53. Cancer Res. 1999. PMID: 10070962

4

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model.

Hammond LA, Hilsenbeck SG, Eckhardt SG, Marty J, Mangold G, MacDonald JR, Rowinsky EK, Von Hoff DD, Weitman S. Hammond LA, et al. Among authors: eckhardt sg. Eur J Cancer. 2000 Dec;36(18):2430-6. doi: 10.1016/s0959-8049(00)00302-6. Eur J Cancer. 2000. PMID: 11094320

5

A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies.

Villalona-Calero MA, Eckhardt SG, Weiss G, Hidalgo M, Beijnen JH, van Kesteren C, Rosing H, Campbell E, Kraynak M, Lopez-Lazaro L, Guzman C, Von Hoff DD, Jimeno J, Rowinsky EK. Villalona-Calero MA, et al. Among authors: eckhardt sg. Clin Cancer Res. 2002 Jan;8(1):75-85. Clin Cancer Res. 2002. PMID: 11801542 Clinical Trial.

6

A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.

Siu LL, Rowinsky EK, Hammond LA, Weiss GR, Hidalgo M, Clark GM, Moczygemba J, Choi L, Linnartz R, Barbet NC, Sklenar IT, Capdeville R, Gan G, Porter CW, Von Hoff DD, Eckhardt SG. Siu LL, et al. Among authors: eckhardt sg. Clin Cancer Res. 2002 Jul;8(7):2157-66. Clin Cancer Res. 2002. PMID: 12114416 Clinical Trial.

7

A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties.

Syed S, Takimoto C, Hidalgo M, Rizzo J, Kuhn JG, Hammond LA, Schwartz G, Tolcher A, Patnaik A, Eckhardt SG, Rowinsky EK. Syed S, et al. Among authors: eckhardt sg. Clin Cancer Res. 2004 Oct 1;10(19):6512-21. doi: 10.1158/1078-0432.CCR-04-0804. Clin Cancer Res. 2004. PMID: 15475438 Clinical Trial.

8

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.

Hammond LA, Eckardt JR, Ganapathi R, Burris HA, Rodriguez GA, Eckhardt SG, Rothenberg ML, Weiss GR, Kuhn JG, Hodges S, Von Hoff DD, Rowinsky EK. Hammond LA, et al. Among authors: eckhardt sg. Clin Cancer Res. 1998 Jun;4(6):1459-67. Clin Cancer Res. 1998. PMID: 9626463 Clinical Trial.

9

Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.

Rowinsky EK, Smith L, Wang YM, Chaturvedi P, Villalona M, Campbell E, Aylesworth C, Eckhardt SG, Hammond L, Kraynak M, Drengler R, Stephenson J Jr, Harding MW, Von Hoff DD. Rowinsky EK, et al. Among authors: eckhardt sg. J Clin Oncol. 1998 Sep;16(9):2964-76. doi: 10.1200/JCO.1998.16.9.2964. J Clin Oncol. 1998. PMID: 9738565 Clinical Trial.

10

A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors.

Diab SG, Baker SD, Joshi A, Burris HA, Cobb PW, Villalona-Calero MA, Eckhardt SG, Weiss GR, Rodriguez GI, Drengler R, Kraynak M, Hammond L, Finizio M, Von Hoff DD, Rowinsky EK. Diab SG, et al. Among authors: eckhardt sg. Clin Cancer Res. 1999 Feb;5(2):299-308. Clin Cancer Res. 1999. PMID: 10037178 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page